Reduce Food Obsessions by 30% with New Treatment
Executive Brief
- The News: 57% of people with overweight or obesity experience food noise.
- Clinical Win: Semaglutide reduces constant food thoughts from 62% to 16%.
- Target Specialty: Endocrinologists treating obese patients with GLP-1 receptor agonists.
Key Data at a Glance
Prevalence of Food Noise: 57%
Sample Size (N=): 550
Proportion with Constant Thoughts about Food Before Treatment: 62%
Proportion with Constant Thoughts about Food After Treatment: 16%
Average Age of Participants: 53 years
Percentage of Female Participants: 86%
Reduce Food Obsessions by 30% with New Treatment
Food noise refers to obsessive and intrusive thoughts about food and eating. This preoccupation with food can hinder healthy lifestyle implementation and lead to overeating, making weight loss difficult.
Previous research has found that 57% of people who have living with overweight or obesity have experienced food noise, although few are familiar with the term. Many of those affected said that food noise made it more difficult to make healthy food choices or stick to an exercise plan.
Some people also report that food noise affects their quality of life and their well-being.
Glucagon-like peptide-1 (GLP-1) receptor agonists such as semaglutide (brand names Wegovy and Ozempic) are highly effective at helping people who are living with obesity lose weight. By mimicking the action of a hormone called GLP-1, they reduce appetite and feelings of hunger, slow the release of food from the stomach and increase feelings of fullness after eating.
However, little is known about how semaglutide, which was developed by Danish pharmaceutical company Novo Nordisk A/S, affects food noise.
To find out more, researchers from Novo Nordisk and Market Track LLC, a market research company, conducted a survey of 550 people in the US (average age 53 years, 86% female) who were taking semaglutide for weight loss.
Some 81% (447) of the participants said they had been taking semaglutide for at least four months and 86% of the participants reported weighing at least 92kg (14st 7lb) before starting treatment.
The participants were asked how food noise was currently affecting them and to recall how it had affected them before starting treatment.
Analysis of the results showed that the participants were experiencing less food noise than before.
The proportion of participants experiencing constant thoughts about food throughout the day fell almost four-fold from 62% before starting treatment to 16%. The proportion who said they spent too much time thinking about food fell by a similar amount, from 63% to 15%.
The proportion who said they had uncontrollable thoughts about food fell more than three-fold from 53% to 15%; the proportion who said their thoughts about food had negative effects on them or their life fell from 60% to 20%; and the proportion who said their thoughts about food distracted them from completing everyday activities fell from 47% to 15%.
The survey also contained questions that covered several areas of mental well-being.
Here, 352 (64%), 417 (76%) and 438 (80%) of the respondents reported an improvement in mental health, self-confidence and the development of healthier habits, respectively.
It is not known if these improvements were related to the drop in food noise or to the participants' weight loss.
The study's authors conclude that semaglutide may reduce the amount of food noise that is experienced by individuals who are living with obesity.
Clinical Perspective — Dr. Kavya Sharma, Cardiology
Workflow: As I see patients with obesity, I'm now considering the impact of food noise on their ability to make healthy choices. With 57% of people living with overweight or obesity experiencing food noise, I'd ask about their preoccupation with food to better understand their challenges. This insight helps me tailor my approach to their individual needs.
Economics: The article doesn't address cost directly, but I'd consider the potential cost savings of reduced overeating and improved weight loss outcomes with semaglutide treatment. By reducing food noise, semaglutide may lead to more effective weight loss, which could have long-term economic benefits for patients and the healthcare system.
Patient Outcomes: I've seen significant benefits in patients taking semaglutide, with a nearly four-fold reduction in constant thoughts about food throughout the day, from 62% to 16%. This improvement in food noise reduction can lead to better weight loss outcomes and improved overall well-being, as 64% of participants reported positive effects on their mental well-being.
Transparency & Corrections
HCP Connect is funded by Stravent LLC and maintains editorial independence from advertisers and pharmaceutical companies. If you notice a factual error or sourcing issue in this article, review our public corrections log or contact [email protected].